OCRvet is a Contract Research Organization focused on conducting clinical trials on dogs and cats with naturally occurring pathologies to assess the efficacy of drug candidates for human health. The company's innovative approach is rooted in ethical research practices, ensuring that the animals involved in the trials benefit from the therapies developed for humans.
Founded in 2011, OCRvet specializes in oncology, inflammation, cardiology, and neurology, offering support to pharmaceutical and biotech companies in advancing their drug development programs. The company's unique proposition lies in its combination of veterinary medicine experts, a multicenter recruitment network, state-of-the-art technical platforms including a histopathology lab and advanced imaging devices, and high-quality standards applied to drug development for human health.